Four New Sets of Pre-Clinical Data Further Expands the Evidence Supporting Abelacimab
/PRNewswire/ -- Anthos Therapeutics, a clinical-stage biotechnology company developing innovative therapies for cardiovascular and metabolic diseases,...
Source: prnewswire.com